3.0
9 Sept 2024
Current employee, more than 3 years
Barcelona
Recommend
CEO approval
Business outlook
Pros
Med Tech footprint and great portfolios
Cons
Still very slow in creating an adequate structure to start performing from 2025
Check out your Company Bowl for anonymous work chats.